Hyperhidrosis is a condition characterised by sweating that exceeds what is required for normal thermoregulation. It most commonly affects the underarms, but can also involve the palms, soles, and face. For many patients it is a source of significant distress affecting clothing choices, social confidence, and professional life on a daily basis.
Types of Hyperhidrosis
Primary hyperhidrosis refers to excessive sweating without an identifiable underlying medical cause. It typically begins in adolescence or early adulthood and tends to affect specific areas symmetrically. Axillary primary hyperhidrosis is the most common presentation.
Secondary hyperhidrosis is associated with an underlying medical condition or medication. It is important to distinguish between primary and secondary hyperhidrosis before treatment is commenced.
Treatment Options
Primary Axillary Hyperhidrosis
For primary axillary hyperhidrosis, a prescription injectable treatment using a well-established neuromodulating medicine is the most clinically effective option available in a non-surgical setting. It works by temporarily blocking the nerve signals that stimulate sweat glands in the treated area, and has a strong clinical response rate in appropriately selected patients. All injectable treatment consultations are conducted under dermatologist supervision.
Less Severe Hyperhidrosis
For patients with less severe hyperhidrosis or who prefer a non-injectable approach, topical treatments and other management strategies may be discussed at consultation.
Severe Primary Axillary Hyperhidrosis
Eligible patients with severe primary axillary hyperhidrosis may be able to access a Medicare rebate for this treatment when performed by a dermatologist, subject to specific clinical criteria being met. Patients are encouraged to discuss their eligibility at their consultation, as this can meaningfully reduce the out-of-pocket cost of treatment.
Your Consultation
At consultation, the practitioner will take a full history, assess the type and severity of the condition, and determine whether primary axillary hyperhidrosis is the appropriate diagnosis. Medicare eligibility criteria will be discussed where relevant. All injectable treatment consultations are conducted under dermatologist supervision. There is no obligation to proceed.
